Clinical Trials Details

EA2186 GIANT (Pancreatic)

A Randomized Phase II Study of Gemcitabine and Nabpaciltaxel with 5-Flourouracil, Luecovorin and Liposomal Irinotecan in Older Patients with treatment naive metastatic pancreatic cancer (GIANT)

Objective

Key eligibility: Untreated metastatic disease; > 70; identified as vulnerable through screening geriatric assessment.

» Learn more about this trial

Clinical Trial Categories

• Cancers and Other Neoplasms